| Research progress of statins in the prevention and treatment of contrast-induced nephropathy |
| Received:August 06, 2020 Revised:September 15, 2020 Click here to download the full text |
| Citation of this paper:ZHOU Lu,ZHAO Qing,WANG Feng.Research progress of statins in the prevention and treatment of contrast-induced nephropathy[J].Chinese Journal of Clinical Medicine,2022,29(2):288-292 |
| Hits: 1138 |
| Download times: 409 |
|
| Abstract:Contrast-induced nephropathy refers to acute kidney injury secondary to exposure to intravascular iodinated contrast agent. In recent years, a lot of evidence has confirmed the effectiveness and safety of statins in the prevention and treatment of contrast-induced nephropathy. This article reviews the latest research progress of statins in the prevention of contrast-induced nephropathy from the aspects of dose, type, duration of medication, impact of individual differences on the efficacy of statins, and the possible mechanism of its kidney protection effects.. |
| keywords:contrast-induced nephropathy statins influencing factors protective mechanism |
| HTML View Full Text View/Add Comment Download reader |
|
|
|